Randomized, Blinded, Placebo-Controlled Trial of High Dose Methotrexate With Leucovorin Rescue (HDMTX-LV) With or Without Glucarpidase in Osteosarcoma.

Trial Profile

Randomized, Blinded, Placebo-Controlled Trial of High Dose Methotrexate With Leucovorin Rescue (HDMTX-LV) With or Without Glucarpidase in Osteosarcoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2014

At a glance

  • Drugs Glucarpidase (Primary) ; Methotrexate
  • Indications Osteosarcoma
  • Focus Pharmacodynamics
  • Sponsors Protherics
  • Most Recent Events

    • 14 Aug 2009 Actual number of patients (8) added as reported by ClinicalTrials.gov.
    • 18 Apr 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Feb 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top